Clinical Trials Browser

Phase 2 × Lovastatin × 30 days × Clear all

NCT07619365 2026-06-02

Trastuzumab Deruxtecan and Lovastatin in HER2-low and Ultralow Advanced or Metastatic Breast Cancer

Phase 2 Not yet recruiting

Breast Neoplasms